J.E. Ang
Impact in
-
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
-
- Lung Cancer Treatments and Mutations
Papers in
-
- Histone Deacetylase Inhibitors Research 2
- Epigenetics and DNA Methylation 1
-
- Sarcoma Diagnosis and Treatment 1
- Renal cell carcinoma treatment 1
- Lung Cancer Treatments and Mutations 1
- Co-authors
- Johann S. de Bono (5 shared papers)Martina Uttenreuther‐Fischer (3 shared papers)James Spicer (3 shared papers)Timothy A. Yap (3 shared papers)Ruth Plummer (1 shared paper)P. Andrew Futreal (1 shared paper)Laura Vidal (1 shared paper)Mehdi Shahidi (2 shared papers)
- Journals
- European Journal of Cancer (2 papers)Journal of Clinical Oncology (1 paper)Annals of Oncology (1 paper)Journal of Thoracic Oncology (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
J.E. Ang
7 papers receiving 340 citations
Peers
Comparison fields: 5 of 34
- Oncology 195
- Pulmonary and Respiratory Medicine 199
- Otorhinolaryngology 8
- Cancer Research 24
- Genetics 17
Countries citing papers authored by J.E. Ang
This map shows the geographic impact of J.E. Ang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.E. Ang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.E. Ang more than expected).
Fields of papers citing papers by J.E. Ang
This network shows the impact of papers produced by J.E. Ang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.E. Ang. The network helps show where J.E. Ang may publish in the future.
Co-authors
The 25 scholars most cited alongside J.E. Ang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 298 | |
| 2 | 2012 | 23 | |
| 3 | 2015 | 22 | |
| 4 | Activity of BIBW 2992, an oral irreversible EGFR/HER2 dual kinase inhibitor, in combination with weekly paclitaxel in non-small cell lung cancer | 2009 | 4 |
| 5 | A phase I study of oral belinostat (PXD101) in patients with advanced solid tumors. | 2007 | 2 |
| 6 | 2024 | 1 | |
| 7 | 2008 | 1 |
About J.E. Ang
J.E. Ang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Reproductive Medicine and Surgery, having authored 7 papers that have together received 351 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (2 papers), HER2/EGFR in Cancer Research (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Epigenetics and DNA Methylation (1 paper), Renal cell carcinoma treatment (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Cutaneous Melanoma Detection and Management (1 paper). The work is most often cited by research in Oncology (195 citations), Pulmonary and Respiratory Medicine (199 citations), Otorhinolaryngology (8 citations), Cancer Research (24 citations) and Genetics (17 citations). J.E. Ang has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Johann S. de Bono, Martina Uttenreuther‐Fischer, James Spicer, Timothy A. Yap, Ruth Plummer, P. Andrew Futreal, Laura Vidal, Mehdi Shahidi, Peter Stopfer and Susan Bell. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.